Cardioprotection by orotic acid: Metabolism and mechanism of action

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 12, 1997, Pages 3239-3250

  Richards, Stephen M ^a   Conyers, Robert A J ^b,c   Fisher, Jane L ^a   Rosenfeldt, Franklin L ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Infarction; Myocardial ischemia; Orotic acid; Purines

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; CYTIDINE; CYTOSINE; OROTIC ACID; PYRIMIDINE DERIVATIVE; URACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; HEART PROTECTION; HEART WORK; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031460847     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0550     Document Type: Article

References (48)

1. ATTARIAN DE, JONES RN, CURRIE WD, HILL RC, SINK JD, OLSEN CO, CHITWOOD JR WR, WESCHLER AS, 1981. Characteristics of chronic left ventricular hypertrophy induced by sub coronary valvular aortic stenosis. II. Response to ischemia. J Thorac Cardiovasc Surg 81: 389-395.
2. AUSSEDAT J, 1983. Effect of uridine supply on glycogen resynthesis after ischemia in the isolated perfused rat heart. Cardiovasc Res 17: 145-151.
3. AUSSEDAT J, RAY A, ROSSI A, 1984. Uridine incorporation in normal and ischemic perfused rat heart. Mol Physiol 6: 247-256.
4. BAILEY LE, 1980. Orotic acid prevents changes in cardiac sarcolemmal glycoproteins and contractility associated with muscular dystrophy in hamsters. Experentia 36: 6-7.
5. BERNAUER W, 1990. Post-ischemic release of nucleosides and oxypurines in isolated rat hearts. Possible involvement of ventricular fibrillation. Basic Res Cardiol 86: 1-10.
6. BEYERSDORF F, ACAR C, BUCKBERG G, 1989. Studies on prolonged acute regional ischemia. III. Early natural history of simulated single and multi vessel disease with emphasis on remote myocardium. J Thorac Cardiovasc Surg 98: 368-380.
7. BONTEMPS F, VINCENT MF, VAN DEN BERGHE G, 1993. Mechanisms of elevation of adenosine concentrations in anoxic hepatocytes. Biochem J 290: 671-677.
8. BRAASCH W, GUDBJARNASON S, PURI P, RAVENS K, BING R, 1968. Early changes in energy metabolism in the myocardium following acute coronary artery occlusion in anesthetised dogs. Circ Res 23: 429-438.
9. DONOHOE JA, ROSENFELDT FL, MUNSCH CM, WILLIAMS JF, 1993. The effect of orotic acid treatment on the energy and carbohydrate metabolism of the hypertrophying rat heart. Int J Biochem 25: 163-182.
10. FAUSTO N, 1972. The conversion of orotic acid into uridine 5′-monophosphate by isolated perfused normal and regenerating rat livers. Biochem J 129: 811-820.
11. GAO WD, ATAR D, LIU Y, PEREZ NG, MURPHY AM, MARBAN E, 1997. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circulation 80: 393-399.
12. GASSER T, MOYER JD, HANDSCHUMACHER RE, 1981. Novel single-pass exchange of circulating uridine in rat liver. Science 213: 777-778.
13. GUDBJARNASON S, PURI PS, MATHES P, 1971. Biochemical changes in non-infarcted heart muscle following myocardial infarction. J Mol Cell Cardiol 2: 253-276.
14. HANDSCHUMACHER RE, COLERIDGE J, 1979. Hepatic and biliary transport of orotate and its metabolic consequences. Biochem Pharmacol 28: 1977-1981.
15. HOLSTEGE A, MANGLITZ D, GEROK W, 1984. Depletion of blood plasma cytidine due to increased hepatocellular salvage in D-galactosamine-treated rats. Eur J Biochem 141: 339-344.
16. JENNINGS RB, STEENBERGEN C JR, 1985. Nucleotide metabolism and cellular damage in myocardial ischemia. Ann Rev Physiol 47: 727-749.
17. KANNENGIESSER GJ, OPIE LH, VAN DER WERF TJ, 1979. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischemic myocardium. J Mol Cell Cardiol 11: 197-207.
18. KEPPLER D, HOLSTEGE A, 1982. Pyrimidine nucleotide metabolism and its compartmentation. In: Sies H (ed.). Metabolic Compartmentation. London: Academic Press, 147-203.
19. KOLOS G, WILLIAMS JF, HICKIE JB, 1974. Biochemical studies in myocardial hypertrophy and metabolic support of the acutely stressed myocardium. Adv Cardiol 12: 106-115.
20. KYPSON J, HAIT G, MATHEW R, 1978. Effects of uridine on the performance and the metabolism of oxygenated and hypoxic rabbit hearts. J Mol Cell Cardiol 10: 545-565.
21. LEA MA, LUKE A, OLIPHANT V, 1988. Selective modulation of nucleotide concentrations in rat liver and hepatomas by high-orotate or arginine-deficient diets and by carbamoylating agents. Biochim Biophys Acta 964: 121-128.
22. LIEDTKE AJ, NELLIS SH, WHITESELL LF, 1982. Effects of regional ischemia on metabolic function in adjacent aerobic myocardium. J Mol Cell Cardiol 14: 195-205.
23. LIN Z, RICHARDS SM, PEPE S, ROSENFELDT FL, 1997. Uridine preserves ATP during hypoxic perfusion of the rat heart. Asia Pacific Heart J (in press).
24. LORTET S, AUSSEDAT J, ROSSI A, 1986. Pyrimidine nucleotide synthesis from exogenous cytidine in the isolated rat heart. Basic Res Cardiol 81: 303-310.
25. MEERSON FZ, 1969. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res 24, 25 (Suppl. 2): II146-II155.
26. MONKS A, AYERS O, CYSYK RL, 1983. Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver. Biochem Pharmacol 32: 2003-2009.
27. MONKS A, CHISENA CA, CYSYK RL, 1985. Influence of ammonium ions on hepatic de novo pyrimidine biosynthesis. Arch Biochem Biophys 236: 1-10.
28. MOYER JD, OLIVER JT, HANDSCHUMACHER RE, 1981. Salvage of circulating pyrimidine nucleosides in the rat. Cancer Res 41: 3010-3017.
29. MUNSCH C, WILLIAMS JF, ROSENFELDT FL, 1989. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: the protective effect of orotic acid. J Mol Cell Cardiol 21: 751-754.
30. MUNSCH CM, ROSENFELDT FL, O'HALLORAN K, LANGLEY LH, CONYERS RAJ, WILLIAMS JF, 1991. The effect of orotic acid on the response of the recently infarcted rat heart to hypothermic cardioplegia. Eur J Cardiothorac Surg 5: 82-93.
31. NEWMAN MAJ, CHEN X-Z, RABINOV M, WILLIAMS JF, ROSENFELDT FL, 1989. Sensitivity of the recently infarcted heart to cardioplegic arrest. J Thorac Cardiovasc Surg 97: 593-604.
32. OLIVARES J, RAY A, AUSSEDAT J, VERDYS M, ROSSI A, 1980. Increased pyrimidine nucleotide synthesis in isoproterenol-induced cardiac hypertrophy in rats. Biochem Biophys Res Commun 95: 367-376.
33. PELS RIJCKEN WR, HOOGHWINKEL GJM, FERWERDA W, 1990. Pyrimidine metabolism and sugar nucleotide synthesis in rat liver. Biochem J 266: 777-783.
34. RASENACK J, NOWACK J, DECKER K, 1978. Pyrimidine nucleotide biosynthesis and turnover in rat skeletal muscle and liver. Eur J Biochem 88: 475-482.
35. ROSSI A, AUSSEDAT J, OLIVARES J, RAY A, VERDYS M, 1984. Pyrimidine nucleotide metabolism in cardiac hypertrophy. Eur Heart J 5 (Suppl. F): 155-162.
36. RUBIO R, BERNE RM, 1980. Localisation of purine and pyrimidine nucleoside phosphorylases in heart, kidney and liver. Am J Physiol 239: H721-H730.
37. SCHAPER W, FRENZEL H, HORT W, 1979. Experimental coronary artery occlusion. I. Measurement of infarct size. Basic Res Cardiol 74: 46-53.
38. SMOLENSKI RT, DE JONG JW, JANSSEN M, LACHNO DR, ZYDOWO MM, TAVENIER M, HUIZER T, YACOUB MH, 1993. Formation and breakdown of uridine in ischemic hearts of rats and humans. J Mol Cell Cardiol 25: 67-74.
39. SNEDECOR GW, COCHRANE WG, 1980. Statistical Methods, 7th Edition. Iowa State University Press, 401.
40. STROBECK JE, SONNENBLICK EH, 1980. Myocardial contractile properties and ventricular performance. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE (eds). The Heart and Cardiovascular System. New York: Raven Press, 31-49.
41. TAEGTMEYER H, HEMS R, KREBS HA, 1980. Utilisation of energy providing substrates in the isolated working rat heart. Biochem J 186: 701-711.
42. VON EULER LH, RUBIN RJ, HANDSCHUMACHER RE, 1963. Fatty livers induced by orotic acid. II. Changes in nucleotide metabolism. J Biol Chem 238: 2464-2469.
43. WILLIAMS JF, DONOHOE J, LYKKE A, KOLOS G, 1976. Studies using orotic acid for improving the controlled development of myocardial hypertrophy. Aust NZ J Med 6 (Suppl. 2): 60-71.
44. WINDMUELLER HG, LEVY RI, 1967. Total inhibition of hepatic beta-lipoprotein production in the rat by orotic acid. J Biol Chem 242: 2246-2254.
45. WYNANTS J, PETROV B, NIJHOF J, VAN BELLE H, 1987. Optimisation of a high-performance liquid chromatographic method for the determination of nucleosides and their catabolites. J Chromatogr 386: 297-308.
46. YEH T JR, REBEYKA IM, JAKOI ER, JOHNSON DE, DIGNAN RJ, DYKE CM, WESCHLER AS, 1994. Orotic acid improves left ventricular recovery four days after heterotopic transplantation. Ann Thorac Surg 58: 409-415.
47. 2+-stimulated ATPase activities in ischemic and non-ischemic areas of the myocardium with acute experimental coronary occlusion. J Mol Cell Cardiol 6: 567-574.
48. ZIMMER H-G, MARTIUS PA, MARSCHNER G, 1989. Myocardial infarction in rats: effects of metabolic and pharmacologic interventions. Basic Res Cardiol 84: 332-343.